Arrowhead Pharmaceuticals Statistics
Total Valuation
ARWR has a market cap or net worth of $8.77 billion. The enterprise value is $8.60 billion.
Important Dates
The next estimated earnings date is Monday, February 9, 2026, after market close.
| Earnings Date | Feb 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ARWR has 137.43 million shares outstanding. The number of shares has increased by 11.67% in one year.
| Current Share Class | 137.43M |
| Shares Outstanding | 137.43M |
| Shares Change (YoY) | +11.67% |
| Shares Change (QoQ) | -0.84% |
| Owned by Insiders (%) | 3.81% |
| Owned by Institutions (%) | 74.77% |
| Float | 118.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.29 |
| Forward PS | 20.31 |
| PB Ratio | 18.59 |
| P/TBV Ratio | 19.11 |
| P/FCF Ratio | 55.92 |
| P/OCF Ratio | 48.86 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 70.33, with an EV/FCF ratio of 54.82.
| EV / Earnings | n/a |
| EV / Sales | 10.37 |
| EV / EBITDA | 70.33 |
| EV / EBIT | 87.45 |
| EV / FCF | 54.82 |
Financial Position
The company has a current ratio of 4.86, with a Debt / Equity ratio of 1.48.
| Current Ratio | 4.86 |
| Quick Ratio | 4.73 |
| Debt / Equity | 1.48 |
| Debt / EBITDA | 5.36 |
| Debt / FCF | 4.74 |
| Interest Coverage | 1.10 |
Financial Efficiency
Return on equity (ROE) is 8.67% and return on invested capital (ROIC) is 5.37%.
| Return on Equity (ROE) | 8.67% |
| Return on Assets (ROA) | 4.87% |
| Return on Invested Capital (ROIC) | 5.37% |
| Return on Capital Employed (ROCE) | 8.27% |
| Revenue Per Employee | $1.17M |
| Profits Per Employee | -$2,294 |
| Employee Count | 711 |
| Asset Turnover | 0.66 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ARWR has paid $21.42 million in taxes.
| Income Tax | 21.42M |
| Effective Tax Rate | 41.56% |
Stock Price Statistics
The stock price has increased by +237.24% in the last 52 weeks. The beta is 1.22, so ARWR's price volatility has been higher than the market average.
| Beta (5Y) | 1.22 |
| 52-Week Price Change | +237.24% |
| 50-Day Moving Average | 58.33 |
| 200-Day Moving Average | 30.73 |
| Relative Strength Index (RSI) | 48.91 |
| Average Volume (20 Days) | 2,605,545 |
Short Selling Information
The latest short interest is 9.63 million, so 7.00% of the outstanding shares have been sold short.
| Short Interest | 9.63M |
| Short Previous Month | 10.23M |
| Short % of Shares Out | 7.00% |
| Short % of Float | 8.12% |
| Short Ratio (days to cover) | 3.60 |
Income Statement
In the last 12 months, ARWR had revenue of $829.45 million and -$1.63 million in losses. Loss per share was -$0.01.
| Revenue | 829.45M |
| Gross Profit | 829.45M |
| Operating Income | 98.35M |
| Pretax Income | 51.53M |
| Net Income | -1.63M |
| EBITDA | 122.27M |
| EBIT | 98.35M |
| Loss Per Share | -$0.01 |
Full Income StatementBalance Sheet
The company has $917.47 million in cash and $743.98 million in debt, with a net cash position of $173.49 million or $1.26 per share.
| Cash & Cash Equivalents | 917.47M |
| Total Debt | 743.98M |
| Net Cash | 173.49M |
| Net Cash Per Share | $1.26 |
| Equity (Book Value) | 503.42M |
| Book Value Per Share | 3.43 |
| Working Capital | 755.15M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $179.55 million and capital expenditures -$22.67 million, giving a free cash flow of $156.89 million.
| Operating Cash Flow | 179.55M |
| Capital Expenditures | -22.67M |
| Free Cash Flow | 156.89M |
| FCF Per Share | $1.14 |
Full Cash Flow StatementMargins
Gross margin is 100.00%, with operating and profit margins of 11.86% and -0.20%.
| Gross Margin | 100.00% |
| Operating Margin | 11.86% |
| Pretax Margin | 6.21% |
| Profit Margin | -0.20% |
| EBITDA Margin | 14.74% |
| EBIT Margin | 11.86% |
| FCF Margin | 18.91% |
Dividends & Yields
ARWR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.67% |
| Shareholder Yield | -11.67% |
| Earnings Yield | -0.02% |
| FCF Yield | 1.79% |
Dividend DetailsAnalyst Forecast
The average price target for ARWR is $73.70, which is 15.45% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $73.70 |
| Price Target Difference | 15.45% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 13.16% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 17, 2011. It was a reverse split with a ratio of 1:10.
| Last Split Date | Nov 17, 2011 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
ARWR has an Altman Z-Score of 1.51 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.51 |
| Piotroski F-Score | 5 |
